Back to results
US 2011/0034473 A1Published application
Novel (pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases
AssigneeNovelix Pharmaceuticals, Inc.
InventorsVictor J. Bauer, Mike H. O'Neill, Barbara J. Kidon, Burkhard Jansen
Life of this patent
Estimating the term…
Abstract
A novel co-crystal of N′-(7-fluoropyrrolo[1,2a]quinoxalin-4-yl)pyrazine-2-carbohydrazide with oxalic acid is disclosed. The disclosed oxalic acid co-crystal demonstrates cancer cell growth inhibition and is more bioavailable than the corresponding free base when administered as a suspension.
Claims16
A compound comprising the co-crystal of N′-(7-fluoropyrrolo[1,2a]quinoxalin-4-yl)pyrazine-2-carbohydrazide with oxalic acid.
Dependencies are inferred from the claim text.